Milliman

Milliman Report Addresses the Potential Impact of Height and Weight on Medical Costs

Published in Cardiovascular Business Week, September 29th, 2009

A new report issued by Milliman reveals the unrealized potential of height and weight characteristics in predicting medical claim costs. The research demonstrates that the commonly used metric for height and weight, the Body Mass Index (BMI), may not be the best indicator of future healthcare costs.

"BMI is a single value calculated as a function of a person's height and weight, and it is often used to categorize relative obesity," says co-author Jon Shreve. "According to the World Health Organization, a person with a BMI of 30 or more is considered obese and thereby considered high risk for chronic diseases, including diabetes and cardiovascular diseases. Our research...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cardiovascular Business Week

Source: Cardiovascular Business Week (2009-09-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry